Not applicableStudy completedNCT05423730What this trial is testingAlcohol and Breast Cancer (ABC) TrialWho this might be right forER+ Breast CancerBreast CancerAromatase Inhibitors Beth Israel Deaconess Medical Center 23
Testing effectiveness (Phase 2)Ended earlyNCT03289039What this trial is testingNeratinib +/- Fulvestrant in HER2+, ER+ Metastatic Breast CancerWho this might be right forBreast Cancer Dana-Farber Cancer Institute 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT06428396What this trial is testingStudy of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029)Who this might be right forMetastatic Breast Cancer Merck Sharp & Dohme LLC 120
Testing effectiveness (Phase 2)Study completedNCT00003199What this trial is testingCombination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast CancerWho this might be right forEstrogen Receptor-negative Breast CancerEstrogen Receptor-positive Breast CancerInflammatory Breast Cancer+5 more Fred Hutchinson Cancer Center 50
Large-scale testing (Phase 3)Active Not RecruitingNCT06065748What this trial is testingEvaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)Who this might be right forEstrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Hoffmann-La Roche 1,050
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07801898What this trial is testingNeoadjuvant Endocrine Therapy Combined With Chemotherapy in ER-positive, HER2-negative Stage I-III Breast CancerWho this might be right forInvasive Breast Cancer (Stage I-III) The Second Hospital of Anhui Medical University 36
Not applicableUnknownNCT03790813What this trial is testingInformative Tools to Optimize Neoadjuvant Therapy in ER Positive, HER2 Negative Breast CancersWho this might be right forBreast Cancer British Columbia Cancer Agency 50
Not applicableStudy completedNCT01928186What this trial is testingFLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast CancerWho this might be right forEstrogen Receptor PositiveHER2/Neu NegativeMale Breast Carcinoma+7 more University of Washington 28
Early research (Phase 1)Active Not RecruitingNCT03900884What this trial is testingPalbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast CancerWho this might be right forBreast Neoplasm Female Peter MacCallum Cancer Centre, Australia 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT03147287What this trial is testingPalbociclib After CDK and Endocrine Therapy (PACE)Who this might be right forMetastatic Breast Cancer Dana-Farber Cancer Institute 220
Testing effectiveness (Phase 2)Study completedNCT01997333What this trial is testingStudy of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast CancerWho this might be right forMetastatic gpNMB Over-expressing Triple Negative Breast Cancer Celldex Therapeutics 327
Large-scale testing (Phase 3)Looking for participantsNCT07242352What this trial is testingMarker - Adjusted Therapy Comparing Adjuvant Elacestrant With Standard Endocrine Treatment in Genomically and/or Clinically High-risk ER+/HER2- eBCWho this might be right forBreast CancerHR+/HER2- Breast Cancer Women's Cancer Study Group GmbH 1,520
Testing effectiveness (Phase 2)WithdrawnNCT01658176What this trial is testingStudy Of PF-04691502 (PI3K/mTOR Inhibitor) In Combination With Exemestane Compared With Exemestane Alone In Patients With Advanced Breast CancerWho this might be right forBreast Neoplasms Pfizer
Large-scale testing (Phase 3)Study completedNCT01101438What this trial is testingA Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast CancerWho this might be right forBreast Cancer Canadian Cancer Trials Group 3,649
Testing effectiveness (Phase 2)Ended earlyNCT01430585What this trial is testingPre-Operative Study of PF-4691502 With Letrozole Compared To Letrozole Alone In Patients With Early Breast CancerWho this might be right forEarly Breast Cancer (Phase 2)Advanced Breast Cancer (Phase 1b) Pfizer 14
Not applicableStudy completedNCT00072293What this trial is testingSurgical Resection With or Without Axillary Lymph Node Dissection in Treating Women With Node-Negative Breast Cancer and Sentinel Lymph Node MicrometastasesWho this might be right forBreast Cancer ETOP IBCSG Partners Foundation 931
Not applicableStudy completedNCT02773004What this trial is testingProspective Study Assessing EndoPredict® Genomic Test Impact on Shared Decision of Adjuvant Chemotherapy in Patients With ER-positive, Her2-negative Early Breast CancerWho this might be right forBreast Cancer UNICANCER 203
Early research (Phase 1)Active Not RecruitingNCT04188548What this trial is testingLY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial CancerWho this might be right forBreast CancerAdvanced Breast CancerMetastatic Breast Cancer+1 more Eli Lilly and Company 379
Early research (Phase 1)Looking for participantsNCT07524855What this trial is testingJNJ-101684362 (HLD-0117) in Patients With Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer Janssen Research & Development, LLC 170
Early research (Phase 1)Study completedNCT03291938What this trial is testingIACS-010759 in Advanced CancersWho this might be right forAdvanced Malignant Solid NeoplasmAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8+22 more M.D. Anderson Cancer Center 29